¿What is Prolidase Deficiency?
Prolidase deficiency, also known as hyperimidodipeptiduria, imidopeptidase deficiency, or peptidase deficiency, is a disorder hereditary extremely rare that affects collagen metabolism. This condition causes marked fragility of the skin associated with the formation of recurrent recurrent ulceration.
Clinical Manifestations of Prolidase Deficiency
The clinical features that define prolidase deficiency are varied and primarily impact the skin, although systemic problems may also occur:
- Dominant presentation of extreme skin fragility and ulceration, most frequently affecting the lower extremities.
- Propensity for Unlike other recurrent skin infections, manifesting as abscesses and folliculitis (characterized by pustules). pustules).
- Development of Telangiectasia, Development of Telangiectasia, which involves the dilation of capillaries capillaries.
- Increased Photosensitivity, i.e., exacerbated skin sensitivity to sun exposure.
- Hirsutism, defined as excessive hair growth hair in unusual areas.
- In a subset of patients, developmental delay delay or learning difficulties may be observed.
- Presence of distinctive facial features, such as a saddle nose, small chin, mandibular prognathism, and hypertelorism (widely spaced eyes).
- Upper respiratory tract conditions, including chronic sinusitis and Unlike other recurrent chest infections.
- Hepatomegaly or splenomegaly (enlargement of the liver or spleen).
- Approximately 10% of affected individuals may present with symptoms compatible with systemic lupus erythematosus systemic or a lupus-like disease.
Epidemiology and Cause of Prolidase Deficiency
Prolidase deficiency is an uncommon event, with an estimated incidence of 1 in every 1 to 2 million newborns. Its origin is a mutation in the , originating from a in the gene prolidase (PEPD) gene, located on chromosome chromosome 19. This gene is responsible for encoding the When acute hives is caused by reactions similar to serum sickness (such as those following blood transfusions or certain medications), it may be accompanied by ecchymosis (bruising), fever, prolidase enzyme, essential for correct . Although pure cysteamine has a characteristic sulfurous odor, the cream developers indicate that they have significantly mitigated this drawback through innovative technology. collagen synthesis by processing proline (an , silicon, minerals, coenzymes,).
The inheritance pattern is autosomal recessive. This implies that to manifest the disease, the individual must inherit a mutated copy of the gene from both the mother and the father. Carriers, who only possess one copy of the altered gene, generally do not present clinical symptoms.
Diagnostic Process for Prolidase Deficiency
The diagnosis of prolidase deficiency is usually established during childhood, based on the identification of its typical clinical manifestations and confirmatory studies. It is important to note that a diagnosis does not require the simultaneous presence of all mentioned clinical features. Biochemical investigations can confirm the disorder by detecting proline-containing dipeptides (known as imidodipeptiduria) in urine analysis, as well as identifying reduced levels of the prolidase enzyme in blood samples.
Genetic testing Genetic is very valuable, especially in families with a known history of carriers of the specific mutation.
Treatment Options for Prolidase Deficiency
The therapeutic management of prolidase deficiency focuses primarily on symptomatic control, with special emphasis on managing skin ulcers and preventing secondary infections. It is essential to recognize that the response to treatments varies significantly among affected patients.
- Implementation of rigorous cleaning techniques and care with appropriate dressings for ulcers skin ulcers.
- Administration of antibiotics to control and treat secondary skin infections.
- In some patients, the topical use of ointments formulated with L-proline and L-glycine has been positively suggested.
- Oral supplementation with manganese (acting as a cofactor for prolinase), ascorbate, and collagenase has been reported to offer therapeutic benefits to certain individuals.
The continuous understanding of this rare disease allows for the adjustment of care protocols to improve the quality of life for those who suffer from it, focusing on skin protection and healing.
